CN102000131A - 一种消癌平片的制备方法 - Google Patents
一种消癌平片的制备方法 Download PDFInfo
- Publication number
- CN102000131A CN102000131A CN 201010564265 CN201010564265A CN102000131A CN 102000131 A CN102000131 A CN 102000131A CN 201010564265 CN201010564265 CN 201010564265 CN 201010564265 A CN201010564265 A CN 201010564265A CN 102000131 A CN102000131 A CN 102000131A
- Authority
- CN
- China
- Prior art keywords
- water
- cancer
- time
- decoct
- hours
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 17
- 201000011510 cancer Diseases 0.000 title abstract description 14
- 206010028980 Neoplasm Diseases 0.000 title abstract description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 42
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims abstract description 16
- 238000002156 mixing Methods 0.000 claims abstract description 13
- 229920002472 Starch Polymers 0.000 claims abstract description 10
- 235000019698 starch Nutrition 0.000 claims abstract description 10
- 239000008107 starch Substances 0.000 claims abstract description 10
- 238000001035 drying Methods 0.000 claims abstract description 8
- 235000019359 magnesium stearate Nutrition 0.000 claims abstract description 8
- 238000000034 method Methods 0.000 claims abstract description 8
- 239000003814 drug Substances 0.000 claims description 37
- 229940079593 drug Drugs 0.000 claims description 28
- 239000000047 product Substances 0.000 claims description 11
- 239000000706 filtrate Substances 0.000 claims description 7
- 238000009495 sugar coating Methods 0.000 claims description 7
- 230000000694 effects Effects 0.000 abstract description 21
- 208000006673 asthma Diseases 0.000 abstract description 16
- 239000000284 extract Substances 0.000 abstract description 9
- 206010058467 Lung neoplasm malignant Diseases 0.000 abstract description 8
- 206010030155 Oesophageal carcinoma Diseases 0.000 abstract description 8
- 208000005718 Stomach Neoplasms Diseases 0.000 abstract description 8
- 206010017758 gastric cancer Diseases 0.000 abstract description 8
- 201000011549 stomach cancer Diseases 0.000 abstract description 8
- 206010009944 Colon cancer Diseases 0.000 abstract description 7
- 208000001333 Colorectal Neoplasms Diseases 0.000 abstract description 7
- 208000032839 leukemia Diseases 0.000 abstract description 7
- 206010067484 Adverse reaction Diseases 0.000 abstract description 5
- 230000006838 adverse reaction Effects 0.000 abstract description 5
- 231100000419 toxicity Toxicity 0.000 abstract description 4
- 230000001988 toxicity Effects 0.000 abstract description 4
- 206010061218 Inflammation Diseases 0.000 abstract description 3
- 230000002708 enhancing effect Effects 0.000 abstract description 3
- 230000001603 reducing effect Effects 0.000 abstract description 3
- 230000004054 inflammatory process Effects 0.000 abstract description 2
- 201000005202 lung cancer Diseases 0.000 abstract description 2
- 208000020816 lung neoplasm Diseases 0.000 abstract description 2
- 235000008216 herbs Nutrition 0.000 abstract 3
- 206010008342 Cervix carcinoma Diseases 0.000 abstract 1
- 208000000461 Esophageal Neoplasms Diseases 0.000 abstract 1
- 241001189830 Fissistigma Species 0.000 abstract 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 abstract 1
- 239000002246 antineoplastic agent Substances 0.000 abstract 1
- 201000010881 cervical cancer Diseases 0.000 abstract 1
- 229940044683 chemotherapy drug Drugs 0.000 abstract 1
- 239000011248 coating agent Substances 0.000 abstract 1
- 238000000576 coating method Methods 0.000 abstract 1
- 230000003467 diminishing effect Effects 0.000 abstract 1
- 201000004101 esophageal cancer Diseases 0.000 abstract 1
- 238000001914 filtration Methods 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 238000005453 pelletization Methods 0.000 abstract 1
- 238000002791 soaking Methods 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 description 13
- 238000011282 treatment Methods 0.000 description 13
- 238000012360 testing method Methods 0.000 description 12
- 238000000605 extraction Methods 0.000 description 11
- 239000000203 mixture Substances 0.000 description 11
- 206010044302 Tracheitis Diseases 0.000 description 9
- 230000001093 anti-cancer Effects 0.000 description 9
- 208000030603 inherited susceptibility to asthma Diseases 0.000 description 8
- 208000017897 Carcinoma of esophagus Diseases 0.000 description 7
- 238000004458 analytical method Methods 0.000 description 7
- 201000005619 esophageal carcinoma Diseases 0.000 description 7
- 208000014829 head and neck neoplasm Diseases 0.000 description 7
- 208000026037 malignant tumor of neck Diseases 0.000 description 7
- 239000012567 medical material Substances 0.000 description 6
- 230000003110 anti-inflammatory effect Effects 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 238000002512 chemotherapy Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 241000411851 herbal medicine Species 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000006187 pill Substances 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 2
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 2
- 102000003712 Complement factor B Human genes 0.000 description 2
- 108090000056 Complement factor B Proteins 0.000 description 2
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 235000019658 bitter taste Nutrition 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 2
- 229940074393 chlorogenic acid Drugs 0.000 description 2
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 2
- 235000001368 chlorogenic acid Nutrition 0.000 description 2
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 230000006866 deterioration Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 239000000321 herbal drug Substances 0.000 description 2
- 238000004811 liquid chromatography Methods 0.000 description 2
- 238000011275 oncology therapy Methods 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000002980 postoperative effect Effects 0.000 description 2
- 208000037920 primary disease Diseases 0.000 description 2
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 2
- 238000001959 radiotherapy Methods 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- 241000208327 Apocynaceae Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000345998 Calamus manan Species 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 241001125690 Marsdenia tenacissima Species 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 238000011887 Necropsy Methods 0.000 description 1
- 206010029098 Neoplasm skin Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 240000005373 Panax quinquefolius Species 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 241000238370 Sepia Species 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 238000000540 analysis of variance Methods 0.000 description 1
- 238000011888 autopsy Methods 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 231100000132 chronic toxicity testing Toxicity 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 230000002498 deadly effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000001156 gastric mucosa Anatomy 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 230000002489 hematologic effect Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 231100000682 maximum tolerated dose Toxicity 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 235000012950 rattan cane Nutrition 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
试验号 | 药材重量(g) | C21甾体皂苷(%) | 绿原酸(%) |
1 | 1500 | 5.6 | 0.014 |
2 | 1500 | 5.5 | 0.016 |
3 | 1500 | 5.3 | 0.016 |
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010105642656A CN102000131B (zh) | 2010-11-29 | 2010-11-29 | 一种消癌平片的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010105642656A CN102000131B (zh) | 2010-11-29 | 2010-11-29 | 一种消癌平片的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102000131A true CN102000131A (zh) | 2011-04-06 |
CN102000131B CN102000131B (zh) | 2012-07-04 |
Family
ID=43807999
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2010105642656A Active CN102000131B (zh) | 2010-11-29 | 2010-11-29 | 一种消癌平片的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102000131B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108478614A (zh) * | 2018-05-21 | 2018-09-04 | 湖北创力药业有限公司 | 一种消癌平片的制备方法 |
CN116509970A (zh) * | 2023-05-22 | 2023-08-01 | 绵阳一康制药有限公司 | 一种通关藤片的制备方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101744854A (zh) * | 2008-12-18 | 2010-06-23 | 海南中化联合制药工业有限公司 | 消癌平滴丸及其制备方法 |
-
2010
- 2010-11-29 CN CN2010105642656A patent/CN102000131B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101744854A (zh) * | 2008-12-18 | 2010-06-23 | 海南中化联合制药工业有限公司 | 消癌平滴丸及其制备方法 |
Non-Patent Citations (1)
Title |
---|
《卫生部颁药品标准(中药成方制剂第12册)》 19971231 国家药典委员会 消癌平片 , 1 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108478614A (zh) * | 2018-05-21 | 2018-09-04 | 湖北创力药业有限公司 | 一种消癌平片的制备方法 |
CN116509970A (zh) * | 2023-05-22 | 2023-08-01 | 绵阳一康制药有限公司 | 一种通关藤片的制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN102000131B (zh) | 2012-07-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101632827B (zh) | 一种治疗银屑病的中药组合物及其制备方法 | |
CN101810715A (zh) | 吴茱萸及其提取物、化合物的新用途 | |
CN101890087A (zh) | 含有黄连、大黄、黄芩的组合物 | |
CN102000304B (zh) | 一种心脑康胶囊的制备方法 | |
CN102000131B (zh) | 一种消癌平片的制备方法 | |
CN102100758B (zh) | 一种用于止痛消肿的青鹏凝胶剂及其制备方法 | |
CN103191191B (zh) | 一种治疗晚期非小细胞肺癌的中药组合物的制备方法 | |
CN105106816A (zh) | 保护化学性肝损伤的中药保健品制剂及其制备方法 | |
CN102000319B (zh) | 一种暖胃舒乐片的制备方法 | |
CN103432420B (zh) | 一种治疗糖尿病的中药组合物及其制备方法和检测方法 | |
CN101850063A (zh) | 一种防治痛风的药物制剂及其制备方法 | |
CN101396492A (zh) | 云南红药胶囊中毒性成分滇乌碱的质量控制方法 | |
Lan et al. | Safety assessment of saponins extract in Dolichos falcatus Klein: subchronic study in Sprague-Dawley rats | |
CN108175801B (zh) | 具有化学性肝损伤保健功能的中药组合物及其制备方法 | |
CN103110890B (zh) | 协日嘎四味有效部位及其制备方法、质量检测方法和应用 | |
CN103479814A (zh) | 一种治疗痛风的中药组合物 | |
CN100340271C (zh) | 一种治疗糖尿病的降糖药物及其制备方法 | |
CN108014226A (zh) | 一种用于减肥的中药 | |
CN102100733B (zh) | 红草止鼾胶囊/片的制备方法 | |
CN103446307A (zh) | 一种治疗糖尿病足的中药组合物 | |
CN100425280C (zh) | 一种治疗类风湿关节炎的中药组合物 | |
CN102579601A (zh) | 一种治疗类风湿性关节炎的药物组合物及其制备方法和用途 | |
CN110075147B (zh) | 景东山橙总生物碱的用途 | |
CN106376928A (zh) | 一种辅助降血糖的复方铁皮石斛保健品制备方法 | |
CN116870078A (zh) | 用于治疗流感的中药组合物及其方法、组合物颗粒和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: GUANGDONG SHANGRUIHE PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: YANGLING WUWEI PHARMACEUTICAL CO., LTD. Effective date: 20140130 |
|
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 712100 XI'AN, SHAANXI PROVINCE TO: 528437 ZHONGSHAN, GUANGDONG PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20140130 Address after: 528437, No. 6, six Yue Jing Road, Torch Development Zone, Guangdong, Zhongshan Patentee after: GUANGDONG SHANGRUIHE PHARMACEUTICAL CO., LTD. Address before: 712100 No. 8 Shennong Road, Yangling demonstration area, Xi'an, Shaanxi Patentee before: Yangling Wuwei Pharmaceutical Group Co., Ltd. |
|
TR01 | Transfer of patent right | ||
C56 | Change in the name or address of the patentee | ||
CP02 | Change in the address of a patent holder |
Address after: 528400 Guangdong province Zhongshan Nanlang town Southern China city of modern Chinese medicine Simiao Road No. 7 Patentee after: GUANGDONG SHANGRUIHE PHARMACEUTICAL CO., LTD. Address before: 528437, No. 6, six Yue Jing Road, Torch Development Zone, Guangdong, Zhongshan Patentee before: GUANGDONG SHANGRUIHE PHARMACEUTICAL CO., LTD. |
|
C56 | Change in the name or address of the patentee | ||
CP01 | Change in the name or title of a patent holder |
Address after: 528400 Guangdong province Zhongshan Nanlang town Southern China city of modern Chinese medicine Simiao Road No. 7 Patentee after: GUANGDONG SINOTAU PHARMACEUTICAL CO., LTD. Address before: 528400 Guangdong province Zhongshan Nanlang town Southern China city of modern Chinese medicine Simiao Road No. 7 Patentee before: GUANGDONG SHANGRUIHE PHARMACEUTICAL CO., LTD. |